173 related articles for article (PubMed ID: 9607579)
21. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
[No Abstract] [Full Text] [Related]
22. FDG-PET for evaluating musculoskeletal tumors: a review.
Aoki J; Endo K; Watanabe H; Shinozaki T; Yanagawa T; Ahmed AR; Takagishi K
J Orthop Sci; 2003; 8(3):435-41. PubMed ID: 12768492
[TBL] [Abstract][Full Text] [Related]
23. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
el-Zeftawy H; Heiba SI; Jana S; Rosen G; Salem S; Santiago JF; Abdel-Dayem HM
Cancer Biother Radiopharm; 2001 Feb; 16(1):37-46. PubMed ID: 11279796
[TBL] [Abstract][Full Text] [Related]
24. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K
Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
van Ginkel RJ; Hoekstra HJ; Pruim J; Nieweg OE; Molenaar WM; Paans AM; Willemsen AT; Vaalburg W; Koops HS
J Nucl Med; 1996 Jun; 37(6):984-90. PubMed ID: 8683328
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography of soft tissue sarcomas.
Israel-Mardirosian N; Adler LP
Curr Opin Oncol; 2003 Jul; 15(4):327-30. PubMed ID: 12874512
[TBL] [Abstract][Full Text] [Related]
27. F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
Peterson JJ
Semin Musculoskelet Radiol; 2007 Sep; 11(3):246-60. PubMed ID: 18260035
[TBL] [Abstract][Full Text] [Related]
28. A PET study of 18FDG uptake in soft tissue masses.
Lodge MA; Lucas JD; Marsden PK; Cronin BF; O'Doherty MJ; Smith MA
Eur J Nucl Med; 1999 Jan; 26(1):22-30. PubMed ID: 9933658
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
Lucas JD; O'Doherty MJ; Cronin BF; Marsden PK; Lodge MA; McKee PH; Smith MA
Br J Surg; 1999 Apr; 86(4):550-6. PubMed ID: 10215835
[TBL] [Abstract][Full Text] [Related]
30. Molecular imaging of sarcomas with FDG PET.
Mendoza H; Nosov A; Pandit-Taskar N
Skeletal Radiol; 2023 Mar; 52(3):461-475. PubMed ID: 36173459
[TBL] [Abstract][Full Text] [Related]
31. PET for sarcomas other than gastrointestinal stromal tumors.
Toner GC; Hicks RJ
Oncologist; 2008; 13 Suppl 2():22-6. PubMed ID: 18434635
[TBL] [Abstract][Full Text] [Related]
32. PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
Lindholm P; Sutinen E; Oikonen V; Mattila K; Tarkkanen M; Kallajoki M; Aro H; Böhling T; Kivioja A; Elomaa I; Minn H
Nucl Med Biol; 2011 Feb; 38(2):295-300. PubMed ID: 21315286
[TBL] [Abstract][Full Text] [Related]
33. 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Link JM; Lewellen TK; Lewellen B; Freeman SD; Mankoff DA; Eary JF; Krohn KA
Clin Cancer Res; 2002 Apr; 8(4):971-9. PubMed ID: 11948102
[TBL] [Abstract][Full Text] [Related]
34. Clinical applications of positron emission tomography in sarcoma management.
Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ
Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039
[TBL] [Abstract][Full Text] [Related]
35. Contemporary imaging in sarcoma.
Landa J; Schwartz LH
Oncologist; 2009 Oct; 14(10):1021-38. PubMed ID: 19789392
[TBL] [Abstract][Full Text] [Related]
36. Spindle Cell Sarcoma of the Iliac Vein on 18 F-FDG PET/CT.
Bek CS; Kim HW; Won KS; Song BI
Clin Nucl Med; 2017 Apr; 42(4):293-294. PubMed ID: 28134693
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning.
Beaulieu S; Rubin B; Djang D; Conrad E; Turcotte E; Eary JF
AJR Am J Roentgenol; 2004 Apr; 182(4):971-4. PubMed ID: 15039173
[TBL] [Abstract][Full Text] [Related]
38. Detection and grading of soft tissue sarcomas of the extremities with (18)F-3'-fluoro-3'-deoxy-L-thymidine.
Cobben DC; Elsinga PH; Suurmeijer AJ; Vaalburg W; Maas B; Jager PL; Hoekstra HJ
Clin Cancer Res; 2004 Mar; 10(5):1685-90. PubMed ID: 15014020
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
Jones DN; McCowage GB; Sostman HD; Brizel DM; Layfield L; Charles HC; Dewhirst MW; Prescott DM; Friedman HS; Harrelson JM; Scully SP; Coleman RE
J Nucl Med; 1996 Sep; 37(9):1438-44. PubMed ID: 8790188
[TBL] [Abstract][Full Text] [Related]
40. PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
Kandathil A; Subramaniam RM
PET Clin; 2017 Oct; 12(4):475-488. PubMed ID: 28867117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
